MCRI
Monarch Casino & Resort, Inc.
MCRI has the edge over TSLA overall, supported by stronger fundamentals and stronger valuation.
TSLA
Tesla, Inc.
TSLA's outlook is improving, though it still trails on the overall score.
MCRI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Strong |
MCRI's profitability, cash flow and balance sheet are currently strong, and its revenue is stable.
TSLA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Strong |
TSLA's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
MCRI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $99.43 | -10% |
| Forward | 16x | $111 | — |
| Current | 18x | $111 | — |
| Fair | 19x | $122 | +10% |
| Expensive | 28x | $176 | +58% |
Historical ranges are pointers, not guarantees.
MCRI has the edge over TSLA in the historical PE scenario, which offers more potential upside but is not a forecast.
TSLA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 60x | $54.70 | -86% |
| Fair | 174x | $158 | -60% |
| Forward | 196x | $397 | — |
| Expensive | 415x | $378 | -4.9% |
| Current | 437x | $397 | — |
Historical ranges are pointers, not guarantees.
TSLA's PE is in its expensive range at 437x. If earnings grow as analysts expect, today's price would be 196x next year's earnings, in its fair range.
MCRI Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect MCRI's earnings to grow and its profitability to improve, with its revenue holding steady.
TSLA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for TSLA, with profitability holding steady. However, they disagree widely on these estimates.
MCRI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.99 | +11% |
| Q3 2026 | $6.31 | +42% |
| Q2 2026 | $6.24 | +48% |
| Q1 2026 | $5.90 | +49% |
| Q4 2025 | $5.43 | +41% |
| Q3 2025 | $4.43 | -2% |
| Q2 2025 | $4.21 | -1.6% |
| Q1 2025 | $3.96 | -6.4% |
| Q4 2024 | $3.84 | -8.6% |
MCRI has the edge over TSLA on earnings, with more consistent year-over-year improvement.
TSLA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.03 | +123% |
| Q3 2026 | $0.91 | -39% |
| Q2 2026 | $1.08 | -38% |
| Q1 2026 | $1.09 | -40% |
| Q4 2025 | $1.08 | -47% |
| Q3 2025 | $1.50 | -59% |
| Q2 2025 | $1.73 | -51% |
| Q1 2025 | $1.82 | -53% |
| Q4 2024 | $2.04 | -53% |
TSLA's earnings per share have fallen from their peak: $0.91 over the past year, against $4.30 in late 2023.
MCRI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $146.3M | +2.4% |
| Q2 2026 | $142.6M | +4.2% |
| Q1 2026 | $136.6M | +8.9% |
| Q4 2025 | $140M | +4.1% |
| Q3 2025 | $142.8M | +3.6% |
| Q2 2025 | $136.9M | +6.8% |
| Q1 2025 | $125.4M | +3.1% |
| Q4 2024 | $134.5M | +4.9% |
MCRI has the edge over TSLA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 28% | +1.5 points |
| Q2 2026 | 27% | +1.6 points |
| Q1 2026 | 26% | +5.4 points |
| Q4 2025 | 21% | +18 points |
| Q3 2025 | 27% | +1.1 points |
| Q2 2025 | 25% | +2.5 points |
| Q1 2025 | 20% | +0.6 points |
| Q4 2024 | 2.9% | -17 points |
MCRI has the edge over TSLA on profitability, with a higher operating margin.
TSLA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $28B | -0.2% |
| Q2 2026 | $28.2B | +26% |
| Q1 2026 | $22.4B | +16% |
| Q4 2025 | $24.9B | -3.1% |
| Q3 2025 | $28.1B | +12% |
| Q2 2025 | $22.5B | -12% |
| Q1 2025 | $19.3B | -9.2% |
| Q4 2024 | $25.7B | +2.1% |
TSLA's revenue has picked up after two years of holding roughly level: $28B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.6% | -3.2 points |
| Q2 2026 | 1.4% | -2.7 points |
| Q1 2026 | 4.2% | +2.1 points |
| Q4 2025 | 5.7% | -0.5 points |
| Q3 2025 | 5.8% | -5 points |
| Q2 2025 | 4.1% | -2.2 points |
| Q1 2025 | 2.1% | -3.4 points |
| Q4 2024 | 6.2% | -2 points |
TSLA's operating margin was 2.6% last quarter, down 3.2 points from the same quarter a year ago, near the bottom of its range since 2019.
MCRI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $41.9M | -22% |
| Q2 2026 | $25.6M | -1.7% |
| Q1 2026 | $43M | +158% |
| Q4 2025 | $32.2M | +23% |
| Q3 2025 | $53.5M | +51% |
| Q2 2025 | $26M | +138% |
| Q1 2025 | $16.6M | -19% |
| Q4 2024 | $26.2M | +20% |
MCRI has the edge over TSLA on cash flow, with more consistent year-over-year improvement.
TSLA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.5B | -62% |
| Q2 2026 | -$1.1B | -848% |
| Q1 2026 | $1.4B | +117% |
| Q4 2025 | $1.4B | -30% |
| Q3 2025 | $4B | +46% |
| Q2 2025 | $146M | -89% |
| Q1 2025 | $664M | +$3.2B |
| Q4 2024 | $2B | -1.6% |
TSLA still generates free cash flow, though less than at its 2025 peak: $3.3B over the past year.
MCRI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -113K shares |
| 1 year | -3.1% | -588K shares |
| 3 years | -7.4% | -1.5M shares |
| 5 years | -6.6% | -1.3M shares |
| Available history | -2.9% | -536K shares |
MCRI has the edge over TSLA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $37.4M |
| Q2 2026 | $212,000 |
| Q1 2026 | $17.7M |
| Q4 2025 | $41.4M |
| Q3 2025 | $11.3M |
| Q4 2024 | $63,000 |
| Q3 2024 | $9.7M |
MCRI spent $97M buying back its own shares over the past year.
TSLA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1M shares |
| 1 year | +0.4% | +15M shares |
| 3 years | +1.4% | +48M shares |
| 5 years | +5.1% | +172M shares |
| Available history | +33% | +886M shares |
TSLA has 3.5B diluted shares, about the same as a year ago.
MCRI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.7x | Net Cash |
| Q2 2026 | -0.7x | Net Cash |
| Q1 2026 | -0.6x | Net Cash |
| Q4 2025 | -0.5x | Net Cash |
| Q3 2025 | -0.7x | Net Cash |
| Q2 2025 | -0.5x | Net Cash |
| Q1 2025 | -0.5x | Net Cash |
| Q4 2024 | -0.4x | Net Cash |
MCRI has more cash than debt.
TSLA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -1.1x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
TSLA has the edge over MCRI on leverage, with a lower net debt burden relative to earnings.
MCRI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.4 | Neutral |
| Stochastic | 13.8 | Oversold |
MCRI's weekly RSI is 41 (neutral) and its Stochastic is 14 (oversold).
TSLA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.3 | Neutral |
| Stochastic | 72.6 | Neutral |
TSLA's weekly RSI is 54 (neutral) and its Stochastic is 73 (neutral).
MCRI PE vs Consumer Cyclical Sector
| Metric | MCRI | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 2.6% below |
| PE % | 33 | 47 | 14 pts below |
MCRI has the edge over TSLA on valuation relative to its sector.
TSLA PE vs Consumer Cyclical Sector
| Metric | TSLA | Sector median | Relative |
|---|---|---|---|
| PE | 437x | 18x | 2,324% above |
| PE % | 84 | 47 | 37 pts above |
TSLA is trading at 437x earnings, a 2324% premium to the Consumer Cyclical sector's median of 18x.
MCRI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $113.3 | 2.1% below |
| 20 week MA | $119.4 | 7.2% below |
| 50 week MA | $110.6 | 0.2% above |
| 100 week MA | $100.0 | 11% above |
| 200 week MA | $85.4 | 30% above |
MCRI has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 30% above its 200-week average.
TSLA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $376.0 | 5.7% above |
| 20 week MA | $364.0 | 9.2% above |
| 50 week MA | $393.6 | 1% above |
| 100 week MA | $372.1 | 6.8% above |
| 200 week MA | $296.9 | 34% above |
TSLA has the edge over MCRI on trend strength, trading above more of its moving averages.
MCRI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $48.1 | $59.5 | +24% |
| 2021 | $59.5 | $73.5 | +24% |
| 2022 | $73.5 | $77.0 | +4.7% |
| 2023 | $77.0 | $69.2 | -10% |
| 2024 | $69.2 | $78.1 | +13% |
| 2025 | $78.1 | $98.3 | +26% |
| 2026 YTD | $98.3 | $110.8 | +13% |
MCRI has the edge over TSLA on returns for 2026, with the stronger performance.
TSLA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.7 | $220.6 | +669% |
| 2021 | $220.6 | $355.7 | +61% |
| 2022 | $355.7 | $123.2 | -65% |
| 2023 | $123.2 | $248.5 | +102% |
| 2024 | $248.5 | $431.7 | +74% |
| 2025 | $431.7 | $475.2 | +10% |
| 2026 YTD | $475.2 | $397.5 | -16% |
TSLA's yearly returns have swung widely, from +669% in 2020 to −65% in 2022. It's down 16% so far in 2026.